Wegovy Cost, GoodRx & the Cheapest Ways Without Insurance

If you have searched "GoodRx Wegovy" or "cheapest semaglutide without insurance," you have run into the same maze everyone does: a sticker price north of a thousand dollars a month, a confusing stack of coupons and savings cards, and a flood of websites promising the same drug for a fraction of the cost. This guide lays out what Wegovy actually costs in mid-2026, which discount routes are real, and where the cheap options stop being the same medicine. Prices move, so everything below is dated as of June 2026 — treat the numbers as ranges to verify, not quotes.

One honest framing up front: Wegovy is a prescription-only drug. Its FDA label restricts it to chronic weight management in adults with obesity (or overweight plus a weight-related condition) and certain adolescents, and it requires a prescriber¹. Nothing here is medical or financial advice — it is a map of the cost landscape so you can have a sharper conversation with a clinician and your insurer.

The list price (and why it is rarely what anyone pays)

Wegovy's published US list price — the manufacturer's wholesale acquisition cost before any insurance or discount — has sat around $1,300–$1,350 for a 28-day supply (four weekly pens). That is the "headline" number you see in news articles, and it is real, but it is also the number the fewest people actually pay. List price matters mainly as the ceiling that every discount below is measured against.

Why so few pay it: between commercial insurance, the manufacturer savings card, the cash self-pay program, and pharmacy discount cards, most people land well under the sticker. The catch is that which discount you qualify for depends entirely on your insurance status — and the routes do not stack the way you might hope.

Route 1: Commercial insurance + the Wegovy savings card

If you have commercial (employer or marketplace) insurance that covers Wegovy for weight loss, the manufacturer's savings card is the cheapest path for most people. Novo Nordisk's WeGoVy Savings Offer has, at various points, brought eligible commercially-insured patients down to a small monthly copay (Novo has advertised figures as low as roughly $0 in the best cases, commonly in the tens of dollars), subject to a monthly and annual cap on what the card pays.

Two honest caveats:

• •It excludes government insurance. If you are on Medicare, Medicaid, TRICARE, or any federal/state plan, you are not eligible for the manufacturer savings card — that is a legal restriction, not a technicality. We map the government-coverage maze, prior authorization, and appeals in Does Insurance Cover Wegovy or Ozempic?.
• •It requires your plan to cover Wegovy in the first place. Many employer plans still exclude anti-obesity medications or gate them behind prior authorization, a documented BMI, or step-therapy. The savings card lowers your copay; it cannot create coverage that your plan does not offer.

Route 2: NovoCare self-pay (direct from the manufacturer) — the cash option

The most important recent change for cash payers is Novo Nordisk's self-pay program through NovoCare, which sells Wegovy directly to people paying out of pocket. It has also moved: as of August 2026 the manufacturer's own pharmacy. He & She MD quotes its twelve-month prepaid rate in every banner, so the figure you see advertised is not the one you pay monthly prices the auto-injector pens rather than the older single-dose vials, at $199/month for a new patient's first two fills (an introductory rate running through 31 December 2026) and $349/month after that, with the 7.2 mg high-dose pen at $399/month and the oral Wegovy tablet at $149/month. Vial pricing no longer appears on the page at all. Those figures are far below list and are the legitimate brand-name cash option — but they buy dispensing only, with no prescriber included.

What you are trading for that price:

• •It is for cash payers, generally meaning you are not running it through insurance.
• •No prescriber is included — NovoCare dispenses only, so you must arrive with a prescription. What the format requires of you is different from using the pre-measured pen — a real usability difference, though the injection technique is the same subcutaneous shot we walk through in How to Inject Wegovy.
• •It is still real, FDA-approved, brand-name semaglutide — the same molecule with the same trial evidence behind it.

For many uninsured or weight-loss-excluded patients, NovoCare self-pay is the honest answer to "cheapest brand-name semaglutide without insurance." A telehealth platform can also route you to the identical NovoCare pens through its own prescriber — Rex MD does exactly that, at one flat cash price stated to hold at every dose — but the platform's own price can land above what NovoCare itself charges for the same pens, which is worth comparing before you assume "brand-name" and "cheapest brand-name" are the same claim.

Route 3: GoodRx and pharmacy discount cards

This is where expectations need recalibrating. GoodRx-type discount cards work best on generic or older drugs, where competition has driven prices down. Wegovy is a single-source brand drug with no generic, so the discounts are modest — pharmacy cash prices with a GoodRx coupon have generally hovered near or slightly below list (often still well over $1,000/month), not the dramatic cuts these cards deliver on, say, generic metformin.

Use a discount card to comparison-shop pharmacy cash prices, and to occasionally beat a bad insurance copay — but for Wegovy specifically, the manufacturer self-pay route typically beats a GoodRx coupon by a wide margin. You generally cannot combine a manufacturer savings card with a GoodRx coupon on the same fill, so pick the cheaper single route. The same logic applies to Ozempic, the diabetes-branded semaglutide; we explain why the two brands price and cover differently in Ozempic vs Wegovy. If cost has you considering Ozempic for weight loss specifically, read Ozempic dosing for weight loss first — it caps at 2 mg and isn't FDA-approved for weight, so the trade-off isn't just about price.

Route 4: Compounded semaglutide — cheaper, but read this carefully

You have seen the ads: telehealth sites offering "semaglutide" for $150–$300 a month, far below even NovoCare self-pay. This is compounded semaglutide, and it deserves an honest, non-promotional explanation, because the savings are real but so are the trade-offs. A low headline is not the same thing as a clean record: Zealthy's compounded price is among the cheapest anywhere, and its parent company has also drawn two FDA warning letters for how it marketed that same price — read the letters before the number. A low headline is also not always the same thing as a low total: Peter MD prices returning patients lower per month than first-timers, yet the returning tier's stated total runs higher over a comparable supply window — a reminder to add up the whole plan, not just the sticker. And a headline monthly figure is not always a monthly figure at all: SkinnyRx advertises the twelve-month rung of its price ladder without calling it a commitment, so the rate you can actually buy one month at a time is a good deal higher than the number on the page. Nor is one seller guaranteed to quote you one price: Try Ageless sells the same compounded semaglutide injection two ways, and the storefront on its own domain lists it for a fraction of what its plan page charges — which page you arrive on decides what you are offered. And a monthly-looking figure is not guaranteed to be billed monthly: WellMedr leads with a semaglutide rate its own banner calls a twelve-month lock-in, then ships the plan every four weeks rather than every month, while its refund policy names a third renewal interval again — three billing intervals on one site, with no month-to-month compounded price published anywhere to check them against. Before you compare any of these against each other, check which plan length the advertised price assumes, check how often the plan actually bills, and check whether the seller has a second, cheaper door. A handful of sellers make that easy: Trellis Vitality prints a one-, three- and six-month table and labels which column is the month-to-month one, and at The Edit every prepay total divides back exactly into the per-month figure printed beside it — $575 for three months really is $192 a month. When a seller shows the division, you can check it; when it shows one number, you cannot. Three more shapes are worth knowing before you compare anything. A month is not always a month: Mondae prices compounded semaglutide at $87 and bills it every 28 days rather than by the calendar, which is thirteen charges a year rather than twelve, so a year costs a full cycle more than the monthly figure implies. An advertised rate is not always a rate: Alinwell advertises $149 a month across its whole site, and its own checkout labels that figure a first-month discount with $249 struck through beside it, and MEDGm's $179 is a welcome coupon applied automatically — remove it and the price panel rewrites itself to $299. And a cheap rate is not always a committed one: Lean Meds sells compounded semaglutide at $79 a month on a one-month plan with no prepay, and states the price does not change as your dose increases, though the $49 its homepage leads with is the twelve-month tier.

Compounded drugs are mixed by a pharmacy rather than manufactured and FDA-approved as a finished product. During 2023–2024, semaglutide's official shortage allowed widespread compounding under the FDA's shortage rules. That shortage was resolved, and the FDA set deadlines after which large-scale compounding of semaglutide copies was no longer permitted under the shortage exemption. The practical situation as of June 2026 is messier than the ads imply:

• •Regulatory status is narrow and shifting. With semaglutide off the shortage list, routine "mass" compounding of straight copies is restricted. Some compounding continues under specific, patient-tailored exemptions (for example, a documented clinical need for a different formulation), but a blanket cheap-copy market is not on the same legal footing it was during the shortage. We trace the full regulatory timeline in is compounded semaglutide still legal in 2026?.
• •It is not FDA-approved, and not the trial product. The robust efficacy and cardiovascular evidence for semaglutide — the STEP 1 weight-loss trial² and the SELECT cardiovascular-outcomes trial³ — was generated with brand-name Novo Nordisk semaglutide, not compounded versions. Compounded products are not tested for that efficacy, and quality, dosing accuracy, and sterility depend entirely on the compounding pharmacy.
• •The FDA has flagged safety concerns, including dosing errors (patients self-measuring from vials and overdosing) and the use of unapproved salt forms (semaglutide sodium / semaglutide acetate) that are not the same as the approved active ingredient.

None of this means every compounded product is dangerous, and many patients use them. But "cheaper" here means stepping outside the FDA-approved supply chain and the evidence base — a genuine gray-market trade-off, not a free lunch. If a price looks far too good and the site is vague about whether it is brand-name or compounded, that is your signal to ask directly — and to check which pharmacy is actually behind the vial, since most providers never say.

Putting it together: which route is actually cheapest for you?

There is no single "cheapest" — it depends on your insurance status as of June 2026, and on whether the figure you are comparing is a month at all: some compounded sellers quote a monthly average of a block billed every twelve weeks with no monthly option behind it, which is 4.33 charges a year rather than twelve. To put real numbers on your own situation, our Wegovy & Ozempic cost calculator estimates your monthly and annual out-of-pocket cost by payment route (and adds any telehealth membership fee):

• •Commercial insurance that covers Wegovy: savings card → usually the lowest copay (tens of dollars, sometimes near $0).
• •Uninsured / weight-loss-excluded plan, want brand-name: NovoCare self-pay pens ($199/month for a new patient's first two fills, then $349/month) → the legitimate cash option.
• •Government insurance (Medicare/Medicaid/TRICARE): not eligible for the savings card; coverage depends on the plan, and many exclude weight-loss use.
• •Lowest possible price: compounded semaglutide ($150–$300) → cheapest, but not FDA-approved, with the regulatory and quality caveats above.

A practical reminder that affects long-term cost: semaglutide manages weight rather than curing it. In the STEP 1 trial extension, people who stopped regained a large share of the lost weight within about a year, so this tends to be ongoing therapy — budget for the long run, not a single month. We unpack that in What Happens If You Stop Semaglutide?. If the recurring price has you asking whether the whole thing pencils out, we weigh the ~15% loss against the indefinite cost in Is Wegovy worth it?. If you are weighing the daily-tablet route as a cost or convenience alternative, see Oral vs Injectable Semaglutide, our look at the oral tablet, Rybelsus, and — for the new obesity-dose tablet specifically — what the oral Wegovy pill costs.

The honest bottom line

Wegovy's list price is high, but it is rarely the price you pay. With commercial coverage, the manufacturer savings card usually wins; without it, NovoCare's self-pay pens are the legitimate cash route; GoodRx-type cards help you comparison-shop but rarely beat those on a brand drug; and compounded semaglutide is the cheapest of all — at the cost of stepping outside FDA approval and the clinical-trial evidence. Verify any number before you commit (prices here are as of June 2026), confirm whether a product is brand-name or compounded, and run the decision past a prescriber. If you'd rather buy online, we map the legitimate telehealth and manufacturer routes — and the membership-fee stacking to watch — in the best places to get Wegovy & Ozempic online. For where to actually start, our best semaglutide providers guide judges each legitimate option on price transparency and oversight, and puts the companies that pay us at the top — stated plainly on the page — and if the only thing you care about is the number, we sort every provider we track cheapest-first in the cheapest semaglutide, in price order, flagging which headline figures are intro rates, memberships or partial doses; both of those rankings, and how they differ, sit on our rankings hub. Want to put two specific programs head to head yourself, with the pharmacy-disclosure facts alongside the price? Our comparison table lines up every provider we track and lets you pick any two directly. That flagging is not academic — Lemonaid bills a mandatory membership underneath every medication price it advertises, Care Bare Rx quotes a floor and holds the per-dose numbers back until you are inside the intake, Breeze Meds does the same, and Effecty is one of the few that publishes brand-name cash prices next to its compounded ones so you can see what the discount actually buys. Our pillar Semaglutide: How It Works, Results & Side Effects covers what the drug does once you are on it. If you are weighing a guided, coach-supported program against a leaner prescription route, our honest provider reviews price each one all-in — see Calibrate, Ro for Wegovy, and Noom.

One provider worth checking against any of these is SnagRx, which holds one price at every dose and publishes its whole commitment ladder — though its headline figure is the twelve-month prepay rung rather than the recurring one.